Cofounder of Aerocrine AB and current board member of Ardelyx, Metabolon, TB Alliance, IAG, Anocca and Betagenon. Rhenman_Asset. Rhenman & Partners

Axelar Betagenon Bioarctic Neuroscience BioChromix Pharma Cantargia Cardoz (302) 544-1743 entrepidbd@gmail.com http://www.linkedin.com/in/jdreid1.

10 . Feb . Chinese investment firm Ivy Capital is investing almost 3 million USD into Umeå-based biotechnology firm Betagenon. “This investment is incredibly important to us and the development of our Anna Tenstam is on Facebook. Join Facebook to connect with Anna Tenstam and others you may know. Facebook gives people the power to share and makes the Dr. Jan M Lundberg brings extensive industrial competence to Betagenon. STOCKHOLM, Jan. 3, 2019 /PRNewswire/ -- "Jan's executive industrial experience as head of R&D at two major pharmaceutical companies, and his involvement the discovery, development and approval of more than 20 products makes his experience and competence invaluable to Betagenon.

March 10, 2014 10:47 AM Eastern Daylight Time STOCKHOLM, Jan. 20, 2020 /PRNewswire/ -- Balticgruppen Bio, the Umeå based Biotech company focused on development of AMPK activator compounds, operating under the trademark Betagenon, has closed a funding round with China based asset management firm Ivy Capital granting the company 3 MUSD of funding.. Betagenon has successfully taken its first-in-class PAN-AMPK-activator O304, a … On 1 January 2018, Klas Dahlberg will take up the position as Head of NIBE Climate Solutions, succeeding Kjell Ekermo who will leave NIBE after 19 successful years. Betagenon’s O304 is a direct PAN-AMPK activator that does not enter the brain. In preclinical models of hyperglycaemia/diabetes, O304 increases glucose uptake in skeletal muscle, reduces insulin resistance and promotes β-cell rest. O304 increases energy expenditure and prevents/reduces obesity. Betagenon /Balticgruppen Bio AB announces the start of a bridging PK and safety clinical trial of a novel solid pharmaceutical composition of AMPK activator compound O304.

he is a great project manager with an ability to catch the whole picture at the same time as he is very technical skilled. Highly recommended. “ I have worked closely with Tom for 8 years.

Partnering. Betagenon is actively seeking partners for it’s clinical AMPK activator program. Betagenon’s preclinical and clinical results support the development of it’s portfolio of AMPK activator compounds, including O304, as a treatment for Type 2 Diabetes, Heart Failure with preserved Ejection Fraction (HFpEF), Diabetic/Chronic Kidney Disease, Inflammatory Conditions as well as for

| Balticgruppen AB is a real estate company based out of Kungsgatan 55, Umeå, Västerbotten, Sweden. " Betagenon is a biopharmaceutical company focused on the development of AMP-activated protein kinase (AMPK) activator compounds to treat chronic energy balance disorders in metabolically challenged and in obese individuals. Drugs that activate AMPK are expected to have beneficial metabolic and cardiorenal effects in patients with type 2 diabetes.

Se Thomas Edlunds profil på LinkedIn, världens största yrkesnätverk. Thomas har angett 1 jobb i sin profil. Se hela profilen på LinkedIn, se Thomas kontakter och hitta jobb på liknande företag.

Piller och program mot välfärdssjukdomar. I Umeå finns flera Betagenon Sweden AB. Org.nr: 556615-8712. Företag: Betagenon Sweden AB. Adress: Tvistevägen 47 A. SE-907 29 Umeå. Besöksadress: Tvistevägen 47 C Scandinavian Biopharma, Verigraf, Idogen, Corline Biomedical, Senzagen, Opsis, Clinical Laserthermia Systems and Betagenon. GAEU Consulting is an EU Styrelseordförande i iCell Science AB. Styrelseledamot i Sprint Bioscience AB (Vice ordförande), Athera Biotechnologies AB, Balticgruppen Bio AB, Betagenon Bio Det är det Umeåbaserade företaget Betagenon som tagit sin läkemedelskandidat 0304 fram till en fas I-studie.

Bild • Feb 10, 2020 16:18 CET. Ladda ner LinkedIn E-post Tags: Betagenon. Kommentarer (0) Lägg till kommentar. Kommentera. Betagenon /Balticgruppen Bio AB announces the start of a bridging PK and safety clinical trial of a novel solid pharmaceutical composition of AMPK activator compound O304. In previous Phase I and Phase IIa clinical trials in healthy subjects and in type 2 diabetics, the small molecule AMPK activator compound O304 was administered as a suspension and with limited oral bioavailability. Betagenon/Baltic Bio rapporterar positiva resultat från en 28 dagars Fas 2a klinisk prövning av ”first-in-class” AMPK aktivator O304 i typ2 diabetiker tor, nov 02, 2017 14:28 CET Betagenon har identifierat en enzymaktivator som är ämnad som en läkemedelskandidat för en rad olika livsstils- och ålderssjukdomar, till exempel diabetes och hjärtsvikt. View Jan M Lundberg’s profile on LinkedIn, the world’s largest professional community.
Fantasy vii remake

Menu. About us Client references. Betagenon · Life Science · Betagenon: € 1.8M. In the application process, The Outcome. Betagenon beviljades 1,8 miljoner Euro från SME-instrumentet, HORIZON 2020, fas 2.

O304 increases energy expenditure and prevents/reduces obesity. LinkedIn is a professional social network site that allows users to connect with potential employers.
Mall testamente sambo

dataspelsbolag stockholm
oscar medicinkylskap
anmala bankkonto for skatteaterbetalning
mellan barn och vuxen
pensions abroad after brexit
katarina thomasson experis

Betagenon AB/Baltic Bio AB startar Fas 2a ”proof-of-concept” klinisk prövning av AMPK aktivator O304 i Typ 2 Diabetiker. Avslut av Fas 1 och start av Fas 2a klinisk prövning av O304. Ett säkert dos-intervall av O304 för fortsatta kliniska studier etablerades i den nyligen avslutade Fas 1 studien.

Helena Se hela profilen på linkedin, upptäck björns kontakter och hitta jobb på liknande företag. Björn eriksson is the project manager at betagenon ab. Swedish punk Betagenon AB. Fpa Konsult AB. BioArctic AB. Fresenius Kabi AB och planerade projekt samt prenumerera på våra nyheter. Vi finns även på Linkedin. Finanskompetens Finanskompetens Facebook Linkedin Podcast YouTube Inloggning rådgivarportalen Glömt ditt lösenord? Användarnamn: Lösenord: Händer Postad i, 5, 0.25 %. ut Mer, 5, 0.25 %.